BVMF/A1SN34 (BVMF/A1SN34)

Brazil Stock Exchange: BVMF/A1SN34 · BRL

R$88.1

-0.29 (-0.3%)· Recorded snapshot

Market cap	88.1B
Revenue (ttm)	6.2B
Net income (ttm)	4.4B
EPS (ttm)	R$4.80
P/E (trailing)	18.4x
P/E (forward)	41.5x
Volume	1
Beta	0.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.2B
Net income (ttm): 4.4B
EPS (ttm): R$4.80
P/E (trailing): 18.4x
P/E (forward): 41.5x
Market cap: 88.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E41.5

P25 n/aP50 n/aP75 n/a

Trailing P/E18.4

P25 n/aP50 n/aP75 n/a

ROE118.8

P25 n/aP50 n/aP75 n/a

ROIC13

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/A1SN34 indicators

Market & fundamental data

Available fields

198

Groups with data

Currency

EUR

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Denmark
Country code	BR
Earnings date	2026-11-12
Employees	1,189
Employees change	172
Employees growth	16.91%
Enterprise value	BRL 85.8B
Exchange	Brazil Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2006
Industry	Biotechnology
Is primary listing	No
ISIN number	BRA1SNBDR008
Last earnings date	2026-08-13
Last refreshed	2026-10-29
Market cap	BRL 88.1B
Next earnings date	2026-11-12
Price	BRL 88.11
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bvmf/A1SN34
Website	https://ascendispharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	5.45%
EV/Earnings	19.55x
EV/EBIT	56.82x
EV/EBITDA	53.12x
EV/FCF	43.27x
EV/Sales	13.35x
FCF / EV yield	2.31%
FCF yield	2.25%
Forward P/E	41.48x
Graham number	28.99852
Graham upside	-67.09%
P/(FCF - SBC) ratio	69.34x
P/(OCF - SBC) ratio	64.98x
P/B ratio	10.36x
P/E ratio	18.36x
P/FCF ratio	44.39x
P/OCF ratio	42.57x
P/S ratio	14.21x
Price / tangible book value	10.38x
Price/EBITDA ratio	56.47x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.7%
EBITDA margin	25.16%
FCF margin	31.55%
Gross margin	91.3%
Operating margin	24.7%
Pretax margin	9.34%
Profit margin	70.84%
Profit per employee	BRL 3.7M
Profitable quarters	2
Revenue per employee	BRL 5.2M
ROA	9.58%
ROA (5Y)	-22.72%
ROCE	14.2%
ROE	118.78%
ROIC	12.98%
SBC / revenue	11.51%
Tax / revenue	-61.5%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-71%
EPS growth quarters	8
EPS growth years	3
Gross profit growth	129.47%
Gross profit growth (Q)	146.15%
Gross profit growth 3Y	116.03%
Gross profit growth 5Y	49.94%
Net income growth (QoQ)	-67.11%
Net income growth quarters	9
Net income growth years	3
Revenue growth	113.35%
Revenue growth (Q)	114.68%
Revenue growth (QoQ)	37.58%
Revenue growth 10Y	66.26%
Revenue growth 3Y	106.35%
Revenue growth 5Y	190.52%
Revenue growth quarters	8
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -85.2M
Depreciation and amortization	BRL 28.8M
EBIT	BRL 1.5B
EBITDA	BRL 1.6B
EPS	BRL 4.80
Financing cash flow	BRL -210.6M
Free cash flow	BRL 2B
Free cash flow minus SBC	BRL 1.3B
Gross profit	BRL 5.7B
Income taxes	BRL -3.8B
Investing cash flow	BRL -77.2M
Net borrowing	BRL -180.9M
Net cash flow	BRL 1.9B
Net income	BRL 4.4B
Operating cash flow minus SBC	BRL 1.4B
Operating income	BRL 1.5B
Revenue	BRL 6.2B
Stock-based compensation	BRL 713.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.97
Book value per share	BRL 129.47
Debt / EBITDA	1.63
Debt / equity	0.31
Debt / FCF	1.34
Interest coverage	2.01
Long-term assets	BRL 5.2B
Long-term liabilities	BRL 2.2B
Net cash (debt)	BRL 2.1B
Net cash / market cap	2.43%
Net debt / EBITDA	-1.37
Net debt / equity	-0.25
Net debt / FCF	-1.08
Piotroski F-Score	7
Property, plant and equipment	BRL 814.7M
Shareholders' equity	BRL 8.5B
Tangible book value	BRL 8.5B
Tangible book value per share	BRL 129.13
Total assets	BRL 13.5B
Total cash	BRL 4.8B
Total debt	BRL 2.7B
Total liabilities	BRL 5B
WACC	7.38%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	BRL 8.3B
Current liabilities	BRL 2.8B
Current ratio	2.99
Inventory turnover	0.3
Net working capital	BRL 1.1B
Quick ratio	2.23
Working capital	BRL 5.5B
Working capital turnover	13.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-6.52%
Shareholder yield	-6.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 60.53
1D price change	-0.33%
1M price change	14.01%
1M total return	14.01%
1W price change	15.21%
1W total return	15.21%
1Y price change	23.28%
1Y return CAGR	23.3%
1Y total return	23.28%
20-day SMA	BRL 84.79
200-day SMA	BRL 53.11
3M price change	0.93%
3M total return	0.93%
3Y price change	195.47%
3Y return CAGR	43.48%
3Y total return	195.47%
50-day SMA	BRL 79.96
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 94.05
52-week high date	2026-07-02
52-week low	BRL 70.00
52-week low date	2026-01-12
6M price change	15.86%
6M total return	15.86%
All-time high	BRL 94.05
All-time high date	2026-07-02
All-time low	BRL 22.32
All-time low date	2023-04-03
Average true range (ATR)	BRL 2.90
Average volume	158.7
Beta (5Y)	0.49
Change from 52-week high	-6.32%
Change from 52-week low	25.87%
Change from all-time high	-6.32%
Change from all-time low	294.76%
Change from open	0%
Day's gap	-0.33%
Dollar volume	BRL 88.11
High price	BRL 88.11
Low price	BRL 88.11
Monthly RSI	65.49
Open price	BRL 88.11
Previous close	BRL 88.40
Price vs 150-day SMA	45.56%
Price vs 20-day SMA	3.91%
Price vs 200-day SMA	65.9%
Price vs 50-day SMA	10.2%
Relative volume	0.01
RSI	56.92
Sharpe ratio	1.7
Sortino ratio	2.65
Volume	1
Weekly RSI	72.23
YTD price change	14.43%
YTD total return	14.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65.6M
Shares change (QoQ)	5.89%
Shares change (YoY)	6.52%
Shares held by insiders	0.02%
Shares held by institutions	80.62%
Short ratio	4.5 days

Deeper analysis on BVMF/A1SN34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/A1SN34 report

Is a complete BVMF/A1SN34 research report available?

No complete published report is available for bvmf/A1SN34 (BVMF/A1SN34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/A1SN34 (BVMF/A1SN34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/A1SN34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/A1SN34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/A1SN34

Frequently asked questions